US Stocks Movement | Vir Biotechnology Surges Over 38% to Hit Highest Level in Over a Year, Q4 Revenue Soars 417% Year-on-Year, Exceeding Expectations
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, February 24|Vir Biotechnology (VIR.US) once surged over 38%, reaching a high of $10.29, marking a new one-year high. In terms of news, Vir Biotechnology's fourth-quarter revenue was $64.07 million, a year-on-year increase of 417%, while the market expectation was $44.16 million; the loss per share was $0.31, compared to a loss of $0.76 per share in the same period last year. In addition, the company announced positive results in the Phase 1 clinical trial of VIR-5500, an investigational therapy for the treatment of late-stage metastatic castration-resistant prostate cancer. (Glonghui)
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Citi: Dell price target lowered to $550
格隆汇•2026/11/16 10:31
Nvidia fell more than 2% in pre-market trading to $159.34.
Odaily星球日报•2026/11/16 10:27

Crypto prices
MoreBitcoin
BTC
$64,471.93
-1.67%
Ethereum
ETH
$1,804.53
-1.37%
Tether USDt
USDT
$0.9990
-0.04%
BNB
BNB
$590.02
-1.23%
USDC
USDC
$0.9996
-0.02%
XRP
XRP
$0.9508
-1.34%
Solana
SOL
$71.37
-0.84%
TRON
TRX
$0.3029
-1.75%
Hyperliquid
HYPE
$67.32
-1.07%
Zcash
ZEC
$889.62
-2.67%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now
